Product Variations
Product # | Price | Quantity | |
---|---|---|---|
VD-OEIA-1026-0010-10mg | $140 | ||
VD-OEIA-1026-0050-50mg | $500 |
$140.00 – $500.00
Off-white solid.
192441-08-0
VD-OEIA-1026
C10H8BrN5OS
326.17
>98 %
Soluble to 100 mM in DMSO
+4°C.
PaTrin-2; 6-[(4-Bromo-2-thienyl)methoxy]-9H-purin-2-amine
10mg, 50mg
Product # | Price | Quantity | |
---|---|---|---|
VD-OEIA-1026-0010-10mg | $140 | ||
VD-OEIA-1026-0050-50mg | $500 |
Inhibitor of O6-methylguanine-DNA methyltransferase (MGMT); (IC50 = 0.009 μM in cell-free extracts from HeLa S3 cells); attenuates MGMT activity in vitro and in vivo. Enhances the antitumor activity of temozolomide in both human melanoma and MCF-7 xenografts.
1. Reinhard et al (2001) Monosaccharide-linked inhibitors of O6-methylguanine-DNA methyltransferase (MGMT): synthesis, molecular modeling, and structure-activity relationships. J.Med.Chem. 44 4050
2. Barvaux et al (2004) Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase. Mol.Cancer Ther. 3 1215.
3. Clemons et al (2005) O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumor MCF-7 cells and xenografts. Br.J.Cancer 93 1152.
Reviews
There are no reviews yet.